AI assistant
BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012
May 14, 2012
30583_dirs_2012-05-14_db3b145c-70d6-4bd0-8adc-a462e9695d9b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-05-12
Reporting Person: Mueller Brian (VP, Corporate Controller)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2012-05-12 | Common Stock | M | 812 | — | Acquired | 14496 | Direct |
| 2012-05-12 | Common Stock | M | 750 | — | Acquired | 15246 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-05-12 | Restricted Stock Units | $0 | M | 812 | Acquired | Common Stock (812) | Direct | |
| 2012-05-12 | Restricted Stock Units | $0 | M | 750 | Acquired | Common Stock (750) | Direct |
Footnotes
F1: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 12, 2009.
F2: Represents restricted stock units which automatically converted to common stock upon the vesting of such units on a one-to-one basis, pursuant to restricted stock units granted May 12, 2010.
F3: Original grant of restricted stock units vest 1/4th each on May 12, 2010, May 12, 2011, May 12, 2012, and May 12, 2013.
F4: Original grant of restricted stock units vest 1/4th each on May 12, 2011, May 12, 2012, May 12, 2013, and May 12, 2014.